Results 61 to 70 of about 1,562,206 (187)

Impact of a change of bronchodilator medications in a hospital drug formulary on intra- and out-of-hospital drug prescriptions: interrupted time series design with comparison group

Implementation Science, 2020
Background Hospital drug formularies are reduced lists of drugs designed to optimise inpatient care. Adherence to the drugs included in such formularies is not always 100% but is generally very high. Little research has targeted the impact of a change in
Raquel Vázquez-Mourelle, Eduardo Carracedo-Martínez, Adolfo Figueiras   +2 more
doaj   +1 more source

Health‐Care Burden of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Hong Kong in the Post‐COVID Pandemic Era—Impact of Phenotype and Exacerbation History

Public Health Challenges, Volume 5, Issue 4, December 2026.
There was an increase in the AECOPD admission numbers after the COVID‐19 pandemic, resulting in increase in health economic burden. ABSTRACT Rationale Chronic obstructive pulmonary disease (COPD) is known to be associated with substantial health‐care utilization and economic costs.
Wang Chun Kwok, Ali Choo, Lu Zhou, Ting Fung Ma, Isaac Sze Him Leung, Chun Ka Wong, James Chung Man Ho   +6 more
wiley   +1 more source

Bronchodilator response cut-off points and FEV 0.75 reference values for spirometry in preschoolers

Jornal Brasileiro de Pneumologia
Objective: To determine the cut-off points for FEV1, FEV0.75, FEV0.5, and FEF25-75% bronchodilator responses in healthy preschool children and to generate reference values for FEV0.75.
Edjane Figueiredo Burity, Carlos Alberto de Castro Pereira, Marcus Herbert Jones, Larissa Bouwman Sayão, Armèle Dornelas de Andrade, Murilo Carlos Amorim de Britto   +5 more
doaj   +1 more source

Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study

Pulmonary Therapy, 2019
Introduction Symptom burden in inadequately controlled chronic obstructive pulmonary disease (COPD) considerably impacts quality of life, healthcare resource utilization (HCRU) and associated costs.
Beth Hahn, Richard H. Stanford, Alyssa Goolsby Hunter, Breanna Essoi, John White, Riju Ray   +5 more
doaj   +1 more source

Advances in New Approach Methodologies at FDA's Division of Applied Regulatory Science

Clinical Pharmacology &Therapeutics, Volume 120, Issue 5, Page 1250-1254, November 2026.
New Approach Methodologies (NAMs) represent a paradigm shift in drug development and regulatory science, offering human‐relevant alternatives to traditional preclinical models. This mini‐review highlights recent advances in NAM development, validation, and regulatory application from FDA's Division of Applied Regulatory Science (DARS).
Ksenia Blinova, Kimberly Chiu, Anik Chaturbedi, Jahan Cooper, Tromondae K. Feaster, Paula L. Hyland, Lidiya Stavitskaya, Wendy W. Wu, Jeffry Florian, Rodney Rouse   +9 more
wiley   +1 more source

Bronchodilator response during acute viral bronchiolitis in infancy

, 1985
Bronchodilator response during acute viral bronchiolitis in ...
LM Taussig (14459280), LI Landau (14458686), E Uren (13369131), PD Sly (14453628), ME Soto (14461353)   +4 more
core   +2 more sources

Integration of Aromatherapy and Essential Oils in Asthma Symptom Relief: A Narrative Review

Health Science Reports, Volume 9, Issue 11, November 2026.
ABSTRACT Background and Aims Asthma affects 262 million people globally, causing 455,000 preventable deaths, with higher mortality in low‐resource areas due to limited diagnosis and treatment. Aromatherapy, using bioactive essential oils (EOs), has emerged as a promising complementary approach for asthma symptom management.
Alex Odoom
wiley   +1 more source

Bronchodilator Responsiveness in Normal Infants and Young Children

http://deepblue.lib.umich.edu/bitstream/2027.42/192028/2/Bronchodilator Responsiveness in Normal Infants and Young Children.pdfPublished versionDescription of Bronchodilator Responsiveness in Normal Infants and Young Children.pdf : Published ...
GOLDSTEIN, AMY B, FLUCKE, ROBERT L, CASTILE, ROBERT G, TEPPER, ROBERT S, McCOY, KAREN S, FILBRUN, DAVID A, DAVIS, STEPHANIE D   +6 more
core   +1 more source

Bronchodilator response assessment through impulse oscillometry system and spirometry in children and adolescents with cystic fibrosis [PDF]

Revista Paulista de Pediatria
Objective: To investigate the effect of bronchodilator on the respiratory mechanics and pulmonary function of children and adolescents with cystic fibrosis.
Tayná Castilho, José Dirceu Ribeiro, Renata Maba Gonçalves Wamosy, Juliana Cardoso, Gabriela Castilhos Ducati, Camila Isabel Santos Schivinski   +5 more
doaj   +1 more source

Cutaneous‐only hypersensitivity reaction presumed due to intravenous administration of atracurium in a dog

Veterinary Record Case Reports, Volume 14, Issue 4, November 2026.
Summary There are limited case reports of hypersensitivity reactions to neuromuscular blocking agents (NMBAs) in veterinary species, and none describe cutaneous‐only signs. This case report describes a Grade 1 cutaneous‐only hypersensitivity reaction to atracurium in a 7‐year‐old dog undergoing general anaesthesia for cataract surgery with bilateral ...
Kar Yee Phoon, Rob Ward
wiley   +1 more source